Previous studies have shown that treating high-fat-diet mice with a monoclonal antibody of CD44 suppresses the development of obesity and reduces adipose tissue inflammation [29]. This evidence concerns the gene CD44 and obesity due to melanocortin 4 receptor deficiency.